octanoic acid has been researched along with Inflammatory Bowel Diseases in 3 studies
octanoic acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #1764
octanoic acid : A straight-chain saturated fatty acid that is heptane in which one of the hydrogens of a terminal methyl group has been replaced by a carboxy group. Octanoic acid is also known as caprylic acid.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mesalamine (5-ASA) is one of the drugs indicated as first line therapy in ulcerative colitis for induction and maintenance of remission." | 7.83 | Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. ( Kandula, M; Palanichamy, S; Rampal, A; Sunil Kumar, KB, 2016) |
| "Mesalamine (5-ASA) is one of the drugs indicated as first line therapy in ulcerative colitis for induction and maintenance of remission." | 3.83 | Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. ( Kandula, M; Palanichamy, S; Rampal, A; Sunil Kumar, KB, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sales, KMO | 1 |
| Cavalcanti, RF | 1 |
| Nobre E Souza, MA | 1 |
| Saraiva, LGM | 1 |
| Braga, LLBC | 1 |
| de Castro, M | 1 |
| Oliveira, RB | 1 |
| Souza, MHLP | 1 |
| De Preter, V | 1 |
| Machiels, K | 1 |
| Joossens, M | 1 |
| Arijs, I | 1 |
| Matthys, C | 1 |
| Vermeire, S | 1 |
| Rutgeerts, P | 1 |
| Verbeke, K | 1 |
| Kandula, M | 1 |
| Sunil Kumar, KB | 1 |
| Palanichamy, S | 1 |
| Rampal, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling[NCT01666717] | 204 participants (Actual) | Observational | 2008-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for octanoic acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Gastroduodenal Symptoms in Inflammatory Bowel Disease Are Correlated with Gastric Emptying and Serum Levels of Active Ghrelin.
Topics: Adult; Aged; Breath Tests; Caprylates; Carbon Isotopes; Case-Control Studies; Duodenum; Female; Gast | 2019 |
Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
Topics: Adolescent; Adult; Aged; Caproates; Caprylates; Case-Control Studies; Colitis, Ulcerative; Crohn Dis | 2015 |
Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Animals; Caprylates; Colitis; Colon; Dextran Sulfate; Drug Discovery; Drug Eva | 2016 |